Ming Jin

Fuzhou, 350122, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Deciphering 14-3-3β-mediated phosphorylated alterations of cancer-related proteome in cisplatin resistance of gastric cancer.

Deciphering 14-3-3β-mediated phosphorylated alterations of cancer-related proteome in cisplatin resistance of gastric cancer.

Journal: International journal of biological macromolecules

Published: September 09, 2025

ANXA11 suppression restores muscular function in the mdx mouse model of Duchenne muscular dystrophy (DMD).

ANXA11 suppression restores muscular function in the mdx mouse model of Duchenne muscular dystrophy (DMD).

Journal: Nature communications

Published: April 08, 2025

ANXA5: related mechanisms of osteogenesis and additional biological functions.

ANXA5: related mechanisms of osteogenesis and additional biological functions.

Journal: Frontiers in cell and developmental biology

Published: December 31, 2024

Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase.

Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase.

Journal: Nature communications

Published: March 18, 2024

Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse.

Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse.

Journal: Molecular therapy. Nucleic acids

Published: July 27, 2023

Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED.

Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 21, 2023

enOsCas12f1-mediated exon skipping for Duchenne muscular dystrophy therapy in humanized mouse model.

enOsCas12f1-mediated exon skipping for Duchenne muscular dystrophy therapy in humanized mouse model.

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: May 14, 2023

Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model.

Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model.

Journal: Nature communications

Published: May 06, 2023

Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase.

Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase.

Journal: National science review

Published: April 24, 2023

Mini-dCas13X-mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy.

Mini-dCas13X-mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy.

Journal: The Journal of clinical investigation

Published: June 17, 2022

Expanding the phenotype and genotype spectra of PLIN4-associated myopathy with rimmed ubiquitin-positive autophagic vacuolation.

Expanding the phenotype and genotype spectra of PLIN4-associated myopathy with rimmed ubiquitin-positive autophagic vacuolation.

Journal: Acta neuropathologica

Published: February 22, 2022

Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene.

Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene.

Journal: Stem cell research

Published: January 30, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026